US Fast Track Boosts Sumitomo's Oncology Pivot

Sumitomo is planning to start a pivotal study for DSP-3665 by the end of its fiscal year 2024.
Sumitomo plans pivotal study for leukemia candidate • Source: Shutterstock

More from R&D

More from Scrip